Childhood Acute Myeloid Leukemia: An Indian Perspective

REFERENCES

• Kulkarni KP, Marwaha RK, Trehan A, Survival outcome in childhood ALL: experience from a tertiary care centre in North India. Pediatr Blood Cancer. 2009;53:168–173.
   PubMed Web of Science ®Google Scholar
• Jain M, Bakhshi S, Shukla AA, Cathepsins B and L in peripheral blood mononuclear cells of pediatric acute myeloid leukemia: potential poor prognostic markers. Ann Hematol. 2010;89:1223–1232.
   PubMed Web of Science ®Google Scholar
• Rubnitz JE, Inaba H, Dahl G, Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010;11:543–552.
   PubMed Web of Science ®Google Scholar
• Friedenreich CM. Methods for pooled analyses of epidemiologic studies. Epidemiology. 1993;4:295–302.
   PubMed Web of Science ®Google Scholar
• Bapna A, Nair R, Tapan KS, All-trans-retinoic acid (ATRA): pediatric acute promyelocytic leukemia. Pediatr Hematol Oncol. 1998;15:243–248.
   PubMed Web of Science ®Google Scholar
• Gujral S, Bhattarai S, Mohan A, Ocular extramedullary myeloid cell tumour in children: an Indian study. J Trop Pediatr. 1999;45:112–115.
   PubMedGoogle Scholar
• George B, Mathews V, Poonkuzhali B, Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience. Leukemia. 2004;18:1587–1590.
   PubMed Web of Science ®Google Scholar
• Sharawat SK, Bakhshi R, Vishnubhatla S, Mitochondrial D-loop variations in paediatric acute myeloid leukaemia: a potential prognostic marker. Br J Haematol. 2010;149:391–398.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Dutta RN, Mukhopadhyay AM, Acute myeloid leukemia of childhood: use of high dose Ara-c in consolidation and interferon in maintenance. Pediatr Blood Cancer. 2004;43:471.
   Google Scholar
• Banavali SD, Biswas G, Nair CN, PRET: an effective oral protocol for out-patient therapy in patients with acute myeloid leukemia (AML) [abstract]. Pediatr Blood Cancer. 2004;43:355.
   Google Scholar
• Goyal L, Banavali SD, Nair R. Preliminary results of acute promyelocytic leukemia (APL) treated with all-trans-retinoic acid (ATRA) and novel oral induction chemotherapy (CT) [abstract]. Pediatr Blood Cancer. 2005:45:527.
   Google Scholar
• Mukhopadhyay S, Chitalkar P, Mukhopadhyay A. Oral chemotherapeutic agents in paediatric acute myeloid leukemia (AML) patients, a study from developing country [abstract]. Pediatr Blood Cancer. 2007;49:528.
   Google Scholar
• Nair V, Singh HP, Sharma A, Paediatric acute myeloid leukemia: experience with intensive chemotherapy protocols [abstract]. Pediatr Blood Cancer. 2007;49:466.
   Google Scholar
• Trehan A, Mehra S, Gupta D, Outcome in children with acute myeloid leukemia in a tertiary centre in North India [abstract]. Pediatr Blood Cancer. 2008;179. (DOI: 10.1002/pbc)
   Google Scholar
• Seth R, Thavaraj V, Velpandian T, Arsenic versus ATRA in acute promyelocytic leukemia: A single center study [abstract]. Pediatr Blood Cancer. 2008:125. (DOI: 10.1002/pbc)
   PubMedGoogle Scholar
• Bansal S, Banavali S, Nair R, Metronomic approach to patients (pts) with acute promyelocytic leukemia (APL) using all-trans-retinoic Acid (ATRA) and oral induction/maintenance Chemotherapy (CT) [abstract]. Pediatr Blood Cancer. 2008:49. (DOI: 10.1002/pbc)
   PubMedGoogle Scholar
• Borker A, Ambulkar I, Goyal S, Pediatric acute myeloid leukemia: single center experience [abstract]. Pediatr Blood Cancer. 2009;53:781.
   Google Scholar
• Sharma P, Bafna V, Mehta P, Infant leukemia: perspective from tertiary care children hospital [abstract]. Pediatr Blood Cancer. 2009;53:779.
   Google Scholar
• Mathews V, George B, Chendamarai E, Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data. J Clin Oncol. 2010; 28:3866–3871.
   PubMedGoogle Scholar
• Biswas S, Chakrabarti S, Chakraborty J, Childhood acute leukemia in West Bengal, India with an emphasis on uncommon clinical features. Asian Pac J Cancer Prev. 2009;10:903–906.
   PubMed Web of Science ®Google Scholar
• Mathews V, George B, Lakshmi KM, Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood. 2006;107:2627–2632.
   PubMed Web of Science ®Google Scholar
• Bakhshi S, Singh P, Swaroop C. Outpatient consolidation chemotherapy in pediatric acute myeloid leukemia: a retrospective analysis. Hematology. 2009;14:255–260.
   PubMed Web of Science ®Google Scholar
• Arora R, Arora B. Delivering childhood cancer services across India: current provisions and future options [abstract]. Pediatr Blood Cancer. 2009;53:887.
   Google Scholar
• Bajel A, George B, Mathews V, Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatr Blood Cancer. 2008;51:621–625.
   PubMed Web of Science ®Google Scholar
• Radhi M, Meshinchi S, Gamis A. Prognostic factors in pediatric acute myeloid leukemia. Curr Hematol Malig Rep. 2010; 5:200–206.
   PubMedGoogle Scholar
• Van Der Velden VH, Van Der Sluijs-Geling A, Gibson BE, Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol. Leukemia. 2010 Jul 29.
   Google Scholar
• Johnston DL, Alonzo TA, Gerbing RB, The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study. Pediatr Blood Cancer. 2010;55:414–420.
   PubMed Web of Science ®Google Scholar
• Marwaha RK, Kulkarni KP, Bansal D, Central nervous system involvement at presentation in childhood acute lymphoblastic leukemia: management experience and lessons. Leuk Lymphoma. 2010;51:261–268.
   PubMed Web of Science ®Google Scholar
• Sander A, Zimmermann M, Dworzak M, Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials. Leukemia. 2010;24:1422–1428.
   PubMed Web of Science ®Google Scholar
• Thirugnanam R, George B, Chendamarai E, Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Biol Blood Marrow Transplant. 2009;15:1479–1484.
   PubMed Web of Science ®Google Scholar